中国医疗前沿
中國醫療前沿
중국의료전연
CHINA HEALTHCARE INNOVATION
2013年
7期
19-20
,共2页
三氧化二砷(As2O3)%肿瘤
三氧化二砷(As2O3)%腫瘤
삼양화이신(As2O3)%종류
Arsenic trioxide%Tumour
三氧化二砷是中药砒霜的主要成分,它被作为药物使用已经有2000多年的历史,最初的应用是治疗梅毒、肺结核等;从20世纪70年代在治疗复发性和难治性急性早幼粒细胞性白血病(APL)中取得较好疗效后,其药用价值开始受到了人们的关注,本世纪初,美国的FDA 批准三氧化二砷用于治疗APL、多发性骨髓瘤(MM)、骨髓增生异常综合征(MDS).自此国内外掀起了研究三氧化二砷的抗肿瘤作用及其机制的热潮,并进行了大量实验,本文就其在抗肿瘤方面的研究进展作一综述.
三氧化二砷是中藥砒霜的主要成分,它被作為藥物使用已經有2000多年的歷史,最初的應用是治療梅毒、肺結覈等;從20世紀70年代在治療複髮性和難治性急性早幼粒細胞性白血病(APL)中取得較好療效後,其藥用價值開始受到瞭人們的關註,本世紀初,美國的FDA 批準三氧化二砷用于治療APL、多髮性骨髓瘤(MM)、骨髓增生異常綜閤徵(MDS).自此國內外掀起瞭研究三氧化二砷的抗腫瘤作用及其機製的熱潮,併進行瞭大量實驗,本文就其在抗腫瘤方麵的研究進展作一綜述.
삼양화이신시중약비상적주요성분,타피작위약물사용이경유2000다년적역사,최초적응용시치료매독、폐결핵등;종20세기70년대재치료복발성화난치성급성조유립세포성백혈병(APL)중취득교호료효후,기약용개치개시수도료인문적관주,본세기초,미국적FDA 비준삼양화이신용우치료APL、다발성골수류(MM)、골수증생이상종합정(MDS).자차국내외흔기료연구삼양화이신적항종류작용급기궤제적열조,병진행료대량실험,본문취기재항종류방면적연구진전작일종술.
Arsenic trioxid is a major component of the traditional Chinese medicine of arsenic, which was used as a drug has a history of over two thousand years, the initial application is the treatment of syphilis, tuberculosis and so on. From the nineteen seventies in the treatment of refractory and relapsed acute promyelocytic leukemia(APL) has good effect, Arsenic's medicinal value began to receive people's attention, At the beginning of this century, U.S. Food and Drug Administration allowed arsenic trioxide to acute promyelocytic leukemia, multiple myeloma and myelodysplastic syndrome.From then on, there was a stirring of interest in antitumor effection and mechanism of arsenic trioxid in domestic and foreign. And a number of experiments has been conducted arounding it.In this paper, the research progress in anti-tumor were reviewed.